Clinical trial
Diffuse Type In-Stent Restenosis After Drug-Eluting Stent
NCT00485030 · Seung-Jung Park, Other · Completed
Key facts
| NCT number | NCT00485030 |
|---|---|
| Title | Diffuse Type In-Stent Restenosis After Drug-Eluting Stent |
| Official title | Comparison Between Drug-Eluting Stents for the Treatment of the Diffuse Type In-Stent Restenosis After Drug-Eluting Stents Implantation: Sirolimus-Eluting vs. Paclitaxel-Eluting Stents |
| Acronym | DES-ISR |
| Lead sponsor | Seung-Jung Park, Other |
| Collaborators | CardioVascular Research Foundation, Korea |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | In-stent Restenosis |
| Intervention type | Device |
| Interventions | Cypher, Xience-V |
| Enrollment | 60 |
| Start date | Mar 1, 2007 |
| Primary completion | Sep 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Jun 12, 2007 |
| Last update posted | Aug 8, 2012 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: